Devang Shah

Savvy Investor.. Not SEBI Registered.

AI isn't replacing human creativity—it's amplifying it.

[Devang Shah @Devangshah23]

Read the aggregate, not the headline.

"Europe is losing its industry to China."

It's the hottest macro narrative right now.

The trade data tells a more interesting story. 🧵

EU's goods deficit with China hit ~€360bn in 2025. Up from €312bn in 2024. Eye-watering.

But here's what the doom-posters skip:

The EU STILL ran an overall goods surplus with the world (~€130bn).

#EU #China #Economics

[Devang Shah @Devangshah23]

The textbook case 👉 $ITC

2018–2021: stock went nowhere for years. Investors called it "dead money." But profits kept compounding and the PE de-rated from ~30x to ~18x. Then 2022–24, sentiment turned, it re-rated back to ~26x — and roughly doubled. The fuel was loaded during the boring years.

The live, unfinished case 👉 $HINDUNILVR

5+ years of near-flat price. PE compressed from a ~70x peak (2021) toward the mid-30s today. But here's the catch: a time correction does NOT guarantee a re-rating. The business has to keep compounding AND sentiment has to return. HUL is still waiting.

That's the risk no one tells you.

The hunting ground:
✅ Strong business, earnings still growing
✅ Price flat/sideways for 1–3 yrs
✅ PE near the low end of its OWN history
✅ A trigger that can revive sentiment
Stop chasing falling knives. Start tracking sleeping compounders.

Not SEBI registered. Educational, not advice. Do your own DD.

#Investing #Fundamentals #Concept #Stocks

[Devang Shah @Devangshah23]

Price correction vs Time correction — the one most retail investors miss 👇

A price correction = the stock FALLS. Obvious. Painful. Everyone notices.

A time correction = the stock goes SIDEWAYS for 1–3 years while earnings keep growing.

Boring, silent... and where some of the biggest re-ratings quietly get built.

#Investing #Concept #Fundamentals

[Devang Shah @Devangshah23]

The math nobody explains:

PE = Price ÷ EPS

If price stays flat but EPS keeps rising, the PE shrinks on its own. Same stock. Same price. Quietly getting cheaper every single quarter.
Illustration:

Yr 0 — ₹100 price, ₹5 EPS → 20x
Yr 3 — ₹100 price, ₹10 EPS → 10x

You didn't lose a rupee. The valuation HALVED while you waited.

#Investing #Fundamentals #Stocks #Concept

[Devang Shah @Devangshah23]

@goenka_sakshi Very much similar to textile industry - Many CFOs in textile cos resigned in last 2 years..

[Devang Shah @Devangshah23]

@vbomkara Sirji, if possible can u share Whats the rationale behind investing in Wendt.. - while Murugappa dint particiapted in OFS, margins as well as Profit is also not showing signs of revivals..

[Devang Shah @Devangshah23]

@Jai0409 No, Carborundum dint bought any share in OFS sold by Wendt GMBH... but from last few weeks this stock is getting attention in social media..

[Devang Shah @Devangshah23]

The most underrated setup in Indian renewables right now 🧵👇:

High PEs are normalizing — but the healthy way.

Earnings are sprinting. Prices are waiting.

$WAAREEENER → profit +101%, P/E ~60x → ~23x

$SUZLON → revenue +54%, P/E 100x+ → ~24x

$KPIGREEN → PAT +57%, P/E ~33x → ~17x

$PREMIERENE → PAT +61%, P/E ~55x → ~32x

Not a crash. A reset.

The froth left. The earnings stayed.

Not investment advice · views personal

[Devang Shah @Devangshah23]

@connectgurmeet So Many People asked question on Tweets - What India Have ?? This is what India have Humanity on Top...

[Devang Shah @Devangshah23]

@Sharad9Dubey @NDTVProfitIndia Good space to looknfor coming years.. Coffee Consumption in India is increasing while organized payers r very few to play the theme... only concern to me in this co is Promoters holding reduced from some 47% to 35% in span of just 2 years...

[Devang Shah @Devangshah23]

🇮🇳 India just moved to fast-track medical device manufacturing.
Health Ministry's draft amendment to Medical Devices Rules, 2017:

📉 Class B (BP monitors, needles, pulse oximeters): 140 → 115 days

📉 Class C/D (cardiac stents, hip/knee implants): 105 → 90 days
Ease-of-doing-business push for a ~$13–15bn sector. 30-day comment window now open — not law yet.

#MedicalDevices #Healthcare #Pharma #Investing

[Devang Shah @Devangshah23]

@NDTVProfitIndia @niraj_shah If possible sirji, kindly do podcast or full detailed interview which will help investors like us to grab next big opportunity..

[Devang Shah @Devangshah23]

@NDTVProfitIndia @niraj_shah Sirji, same here supper bullish on Mid Size & Small Size Pharma Cos.. as well as CDMO & CRDMO looks very bullish for future..

[Devang Shah @Devangshah23]

Specialty-chemicals CDMO (often serving agro + pharma)..

The "CSM/CRAMS" cousins — custom synthesis, frequently more agrochem than pharma, but theme-adjacent:

1) PI Industries — agrochem CSM leader (the gold standard in agro custom synthesis).

2) Navin Fluorine — fluorine-based CDMO/CRAMS (pharma + agro + specialty).

3) SRF — chemicals with a growing pharma/agro CDMO piece.

4) Aarti Industries — specialty chemicals with custom-synthesis contracts.

5) Anupam Rasayan — agrochem + specialty CSM (long-term contracts).

6) Vinati Organics, Clean Science — specialty chemicals, custom/proprietary (more product than contract, but adjacent).

#API #Chemicals #Pharma #Biology

[Devang Shah @Devangshah23]

Pure-play / CDMO-CRDMO is the core business

These are the cleanest ways to play the theme:

1) Syngene International — the integrated CRDMO (Biocon subsidiary), discovery-to-manufacturing, dedicated centers.

2) Sai Life Sciences — integrated CRDMO, "follow the molecule," IPO'd Dec 2024.

3) Anthem Biosciences — CRDMO with the broadest modality range (fermentation, small molecule, biologics, ADC, RNAi), IPO'd 2025.

4) Divi's Laboratories — technically the largest; custom synthesis + generic APIs (more API+CDMO hybrid, but CDMO is huge).

5) Cohance Lifesciences — formed from the Suven Pharma + Cohance merger (Advent-backed), small molecule + ADC CDMO.

6) Concord Biotech — fermentation-based API/CDMO (immunosuppressants, anti-infectives).

7) Neuland Laboratories — CMS (custom manufacturing solutions) + APIs; CMS arm is the CDMO play.

#CDMO #CRDMO #API #Pharma

[Devang Shah @Devangshah23]

Significant CDMO arm within a larger pharma/API business..

CDMO is a real and growing slice, but not the whole company:

1) Piramal Pharma — CDMO + complex hospital generics + consumer health; CDMO is a major segment.

2) Laurus Labs — APIs + formulations with a fast-growing CDMO/synthesis division.

3) Gland Pharma — injectables, more B2B/CMO in sterile injectables.

4) Suven Pharmaceuticals — specialty chemicals + pharma CDMO (note: tied into the Cohance entity now).

5) Aarti Pharmalabs — APIs + CDMO/CMS (demerged from Aarti Industries).

6) Jubilant Pharmova — CDMO (sterile injectables, CRO via Jubilant Biosys) within a diversified pharma group.

7) Blue Jet Healthcare — contrast media + pharma intermediates (CDMO-like specialty).

8) Sequent Scientific / Viyash — animal-health APIs + CDMO.

9) Shilpa Medicare — APIs + formulations + growing CDMO.

#CDMO #CRDMO #API #Pharma

[Devang Shah @Devangshah23]

Commodity mania is getting a brutal reality check. #Gold is off the highs, #silver has been crushed, and crude is sliding back toward pre-war levels. The market is screaming one thing: the fear premium is being erased, and the commodity supercycle narrative needs a serious reset.

Said Earlier - Crowded Trades dont ends politely...

#Commodity #Investing

[Devang Shah @Devangshah23]

@EquityValueIn @grok which indian co. Is having the highest Capex , as well has highest compounds delivered and turned the highest number of molecules from R&D to scalability...

[Devang Shah @Devangshah23]

Crude Oil - Scare for India & Global Economy is going back to Square 1.. Inflation to Adjust very soon, while now its time for Countries & Oil OMCs to reduce the prices asap for people.

#Oil #Crude #Inflation #OMC

[Devang Shah @Devangshah23]

CrudeOil - After U.S - Iran Peace Deal - crude is at $80.8. If any close below 80$ we could see sub $65 levels from where the rally as started...

Is Crude Going Back Home..??
#Crudeoil #Peace #IranWar‌ #hormuz_strait

[Devang Shah @Devangshah23]

Yesterdays , NVIDIA posted Water usage has been a hot topic in the AI data center world, but the numbers may surprise you.

According to the Manhattan Institute, data centers use 0.2 percent of daily water usage in the U.S. and that number has dramatically decreased in the past few years due to a new method: liquid cooling.

By moving to 45°C liquid cooling, AI factories in favorable climates can use dry coolers instead of conventional cooling-tower-based systems, cutting facility cooling water use from roughly 2.6M gallons per MW per year to near zero.

Liquid cooling enables AI factories to be both water and energy efficient, while creating opportunities for heat reuse and dispersal to local communities, allowing these factories to become energy grid assets.

If Cooling system works - Stocks like SRF, Navin Fluro would be huge beneficary which market are not seeing this..

[Devang Shah @Devangshah23]

@elonmusk Gr8 Achievement 👍👍